A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
Clinical trial NCT07450859 · RECRUITING
Trial details
- NCT number
- NCT07450859
- Sponsor
- BicycleTx Limited
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-05
- Primary completion
- 2029-03-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.